Free tool
Healthcare stocks
We cover 928 companies in the Healthcare sector. The median market value in the group is $704.45M. Across the group, the median move over the past trading day is 0.00%. 56% of the 895 with a 200-day average trade above it. Price change over the past year runs from −38.5% to +144.2% across the middle 80 percent of the group, with a median of +9.6%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
928 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LILY34.SA | Eli Lilly and Company | $1.10T | Mega cap | +59.83% |
| LLY | Eli Lilly and Company | $1.06T | Mega cap | +62.80% |
| LLY.DE | Eli Lilly and Company | $1.05T | Mega cap | +65.95% |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% |
| JNJB34.SA | Johnson & Johnson | $658.09B | Mega cap | +47.82% |
| JNJ.DE | Johnson & Johnson | $641.00B | Mega cap | +57.15% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% |
| ABBV34.SA | AbbVie Inc. | $467.00B | Mega cap | +21.88% |
| 4AB.DE | AbbVie Inc. | $457.78B | Mega cap | +29.91% |
| RHO.DE | Roche Holding AG | $368.45B | Mega cap | +39.25% |
| N1VS34.SA | Novartis AG | $301.83B | Mega cap | +20.04% |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% |
| NOT.DE | Novartis AG | $294.64B | Mega cap | +28.48% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% |
| A1ZN34.SA | AstraZeneca PLC | $258.63B | Mega cap | +0.13% |
| AZN.L | AstraZeneca PLC | $256.20B | Mega cap | +3.37% |
| AZN.ST | AstraZeneca PLC | $255.60B | Mega cap | +3.69% |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| AMG.DE | Amgen Inc. | $238.01B | Mega cap | +57.84% |
| TN8.DE | Thermo Fisher Scientific Inc. | $232.14B | Mega cap | +28.91% |
| N1VO34.SA | Novo Nordisk A/S | $208.90B | Mega cap | −17.86% |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −13.32% |
| NOVO-B.CO | Novo Nordisk A/S | $206.43B | Mega cap | −13.55% |
| NOV.DE | Novo Nordisk A/S | $206.12B | Mega cap | +12.94% |
| NVO.WA | Novo Nordisk A/S | $200.44B | Mega cap | −7.94% |
| PODD | Insulet Corporation | $9.94B | Mid cap | −57.12% |
| PTGX | Protagonist Therapeutics, Inc. | $9.80B | Mid cap | +146.62% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +62.83% |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +83.55% |
| KRK.WA | Krka, d. d. | $9.44B | Mid cap | +35.83% |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% |
| DEMANT.CO | Demant A/S | $9.39B | Mid cap | +16.89% |
| WDH1.DE | Demant A/S | $9.33B | Mid cap | −8.29% |
| PCVX | Vaxcyte, Inc. | $9.09B | Mid cap | +99.97% |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −5.08% |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% |
| 4151.T | Kyowa Kirin Co., Ltd. | $8.74B | Mid cap | +5.98% |
| BRKR | Bruker Corporation | $8.69B | Mid cap | +70.56% |
| ATR | AptarGroup, Inc. | $8.60B | Mid cap | −1.89% |
| 4523.T | Eisai Co., Ltd. | $8.53B | Mid cap | +9.77% |
| TGTX | TG Therapeutics, Inc. Common Stock | $8.42B | Mid cap | +92.61% |
| ALKS | Alkermes plc | $8.25B | Mid cap | +68.07% |
| SYRE | Spyre Therapeutics, Inc. | $8.13B | Mid cap | +446.12% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +9.35% |
| 2413.T | M3, Inc. | $7.76B | Mid cap | −13.96% |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% |
| 6869.T | Sysmex Corporation | $7.42B | Mid cap | +7.21% |
| ALK-B.CO | ALK-Abelló A/S | $7.35B | Mid cap | +6.87% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.24B | Mid cap | +54.22% |
| SHL.AX | Sonic Healthcare Limited | $7.13B | Mid cap | −12.74% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% |
| PACS | PACS Group, Inc. | $7.03B | Mid cap | +274.28% |
| HIMS | Hims & Hers Health, Inc. | $6.96B | Mid cap | −32.22% |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | $6.77B | Mid cap | +11.33% |
| ERAS | Erasca, Inc. | $6.70B | Mid cap | +1112.03% |
| 3391.T | Tsuruha Holdings Inc. | $6.66B | Mid cap | +4.03% |
| E2XE34.SA | Exelixis, Inc. | $6.61B | Mid cap | +23.92% |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +77.38% |
| ORKA | Oruka Therapeutics, Inc. | $6.58B | Mid cap | +555.07% |
| RADL3.SA | Raia Drogasil S.A. | $6.56B | Mid cap | +7.42% |
| 3088.T | MatsukiyoCocokara & Co. | $6.47B | Mid cap | −12.29% |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +6.85% |
| COH.AX | Cochlear Limited | $6.39B | Mid cap | −53.99% |
| COGT | Cogent Biosciences, Inc. | $6.39B | Mid cap | +196.85% |
| 7747.T | Asahi Intecc Co., Ltd. | $6.34B | Mid cap | +52.84% |
| BLTE | Belite Bio, Inc | $6.31B | Mid cap | +144.07% |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +154.86% |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.27B | Mid cap | +92.20% |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +64.11% |
| BLCO.TO | Bausch + Lomb Corporation | $6.18B | Mid cap | +19.34% |
| BLCO | Bausch + Lomb Corporation | $6.16B | Mid cap | +18.56% |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +356.93% |
| STVN | Stevanato Group S.p.A. | $6.11B | Mid cap | −0.09% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $6.07B | Mid cap | +46.02% |
| CTEC.L | Convatec Group PLC | $6.06B | Mid cap | −2.44% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.05B | Mid cap | +133.47% |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +7.27% |
| T1FX34.SA | Teleflex Incorporated | $6.00B | Mid cap | +0.29% |
| SECT-B.ST | Sectra AB (publ) | $5.99B | Mid cap | −10.34% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +31.96% |
| DFTX | Definium Therapeutics, Inc. | $5.88B | Mid cap | +344.37% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| LGND | Ligand Pharmaceuticals Incorporated | $5.74B | Mid cap | +80.92% |
| CRSP | CRISPR Therapeutics AG | $5.73B | Mid cap | +10.65% |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% |
| MMED | MiniMed Group, Inc. | $5.48B | Mid cap | +5.41% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% |
| GRFS | Grifols, S.A. | $5.38B | Mid cap | −19.39% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | $5.02B | Mid cap | −10.75% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% |
| EWTX | Edgewise Therapeutics, Inc. | $4.80B | Mid cap | +207.13% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | $4.70B | Mid cap | +68.60% |
| LFST | LifeStance Health Group, Inc. | $4.69B | Mid cap | +121.31% |
| CELC | Celcuity Inc. | $4.65B | Mid cap | +90.31% |
| WAY | Waystar Holding Corp. | $4.63B | Mid cap | −34.97% |
| 000100.KS | Yuhan Corporation | $4.63B | Mid cap | −24.80% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.56B | Mid cap | −8.60% |
| BLLN | BillionToOne, Inc. | $4.54B | Mid cap | −11.68% |
| ICUI | ICU Medical, Inc. | $4.49B | Mid cap | +41.83% |
| NVST | Envista Holdings Corporation | $4.47B | Mid cap | +30.89% |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.43B | Mid cap | −0.74% |
| DOCS | Doximity, Inc. | $4.41B | Mid cap | −63.61% |
| LIVN | LivaNova PLC | $4.41B | Mid cap | +41.56% |
| MANE | Veradermics, Incorporated | $4.29B | Mid cap | +172.32% |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +269.13% |
| RLAY | Relay Therapeutics, Inc. | $4.26B | Mid cap | +445.10% |
| INDV | Indivior Pharmaceuticals, Inc. | $4.23B | Mid cap | +47.06% |
| 4506.T | Sumitomo Pharma Co., Ltd. | $4.18B | Mid cap | −2.62% |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.14B | Mid cap | +3.26% |
| IRTC | iRhythm Holdings, Inc. | $4.06B | Mid cap | −29.83% |
| LEGN | Legend Biotech Corporation | $4.02B | Mid cap | −40.44% |
| VKTX | Viking Therapeutics, Inc. | $4.01B | Mid cap | +29.15% |
| DNLI | Denali Therapeutics Inc. | $3.98B | Mid cap | +57.50% |
| MCOV-B.ST | Medicover AB (publ) | $3.92B | Mid cap | −6.91% |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% |
| BBZA.DE | BB Biotech AG | $3.87B | Mid cap | +7.22% |
| FIE.DE | Fielmann Group AG | $3.86B | Mid cap | −24.08% |
| 000105.KS | Yuhan Corporation | $3.84B | Mid cap | −31.22% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.82B | Mid cap | +7.19% |
| CAMX.ST | Camurus AB (publ) | $3.80B | Mid cap | −15.56% |
| TLX | Telix Pharmaceuticals Limited | $3.77B | Mid cap | −8.02% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.72B | Mid cap | +20.92% |
| 7459.T | MediPal Holdings Corporation | $3.70B | Mid cap | +12.97% |
| IOVA | Iovance Biotherapeutics, Inc. | $3.66B | Mid cap | +233.88% |
| OPCH | Option Care Health, Inc. | $3.60B | Mid cap | −15.91% |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% |
| GPCR | Structure Therapeutics Inc. | $3.56B | Mid cap | +159.74% |
| GRAL | GRAIL, Inc. | $3.55B | Mid cap | +136.66% |
| QURE | uniQure N.V. | $3.53B | Mid cap | +223.49% |
| NHC | National HealthCare Corporation | $3.53B | Mid cap | +103.83% |
| ZEAL.CO | Zealand Pharma A/S | $3.39B | Mid cap | −25.81% |
| 22Z.DE | Zealand Pharma A/S | $3.36B | Mid cap | −29.60% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% |
| AFX.DE | Carl Zeiss Meditec AG | $3.28B | Mid cap | −25.79% |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.27B | Mid cap | +11.97% |
| 3349.T | COSMOS Pharmaceutical Corporation | $3.24B | Mid cap | −25.81% |
| MBX | MBX Biosciences, Inc. | $3.22B | Mid cap | +366.53% |
| BEAM | Beam Therapeutics Inc. | $3.21B | Mid cap | +79.06% |
| TMDX | TransMedics Group, Inc. | $3.19B | Mid cap | −21.43% |
| CLDX | Celldex Therapeutics, Inc. | $3.19B | Mid cap | +79.51% |
| IRON | Disc Medicine, Inc. | $3.17B | Mid cap | +37.90% |
| VIRP.PA | Virbac SA | $3.17B | Mid cap | −3.58% |
| WRBY | Warby Parker Inc. | $3.15B | Mid cap | −3.96% |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.12B | Mid cap | +60.64% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.10B | Mid cap | +22.19% |
| BIOA-B.ST | BioArctic AB (publ) | $3.10B | Mid cap | +10.37% |
| ALMS | Alumis Inc. | $3.06B | Mid cap | +380.08% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $3.04B | Mid cap | −20.70% |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.69% |
| BKD | Brookdale Senior Living Inc. | $2.91B | Mid cap | +55.61% |
| ALHC | Alignment Healthcare, Inc. | $2.88B | Mid cap | −13.88% |
| AMBU-B.CO | Ambu A/S | $2.87B | Mid cap | −25.78% |
| ACHC | Acadia Healthcare Company, Inc. | $2.85B | Mid cap | +37.81% |
| B72.DE | AtaiBeckley Inc. | $2.79B | Mid cap | +59.69% |
| SLS | SELLAS Life Sciences Group, Inc. | $2.77B | Mid cap | +615.10% |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% |
| VRDN | Viridian Therapeutics, Inc. | $2.75B | Mid cap | +30.71% |
| 9989.T | Sundrug Co.,Ltd. | $2.74B | Mid cap | −16.61% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% |
| RGC | Regencell Bioscience Holdings Limited | $2.72B | Mid cap | −61.38% |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% |
| VERA | Vera Therapeutics, Inc. | $2.65B | Mid cap | +67.21% |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% |
| EBO.AX | EBOS Group Limited | $2.64B | Mid cap | −37.11% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.61B | Mid cap | −0.42% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.61B | Mid cap | −12.10% |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% |
| BHVN | Biohaven Ltd. | $2.56B | Mid cap | +8.65% |
| TRVI | Trevi Therapeutics, Inc. | $2.55B | Mid cap | +124.00% |
| 2784.T | Alfresa Holdings Corporation | $2.54B | Mid cap | +7.30% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +151.95% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.51B | Mid cap | +15.38% |
| CURA.TO | Curaleaf Holdings, Inc. | $2.51B | Mid cap | +197.74% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.50B | Mid cap | +8.81% |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +321.09% |
| PBH | Prestige Consumer Healthcare Inc. | $2.47B | Mid cap | −22.12% |
| NUVB | Nuvation Bio Inc. | $2.44B | Mid cap | +135.93% |
| BHC | Bausch Health Companies Inc. | $2.43B | Mid cap | −10.45% |
| BHC.TO | Bausch Health Companies Inc. | $2.43B | Mid cap | −9.88% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.42B | Mid cap | +72.02% |
| KLRA | Kailera Therapeutics, Inc. | $2.39B | Mid cap | −29.08% |
| OCUL | Ocular Therapeutix, Inc. | $2.37B | Mid cap | −12.58% |
| ALMR | Alamar Biosciences, Inc. | $2.36B | Mid cap | +54.91% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +45.50% |
| 009420.KS | Hanall Biopharma Co., Ltd. | $2.36B | Mid cap | +116.42% |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +41.94% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +21.43% |
| BFLY | Butterfly Network, Inc. | $2.30B | Mid cap | +450.32% |
| COAG | Hemab Therapeutics Holdings, Inc. | $2.30B | Mid cap | +44.68% |
| MSB.AX | Mesoblast Limited | $2.30B | Mid cap | +12.84% |
| MLYS | Mineralys Therapeutics, Inc. | $2.28B | Mid cap | +70.22% |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +394.99% |
| CLOV | Clover Health Investments, Corp. | $2.26B | Mid cap | +57.99% |
| NANO.PA | Nanobiotix S.A. | $2.25B | Mid cap | +387.64% |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% |
| URGN | UroGen Pharma Ltd. | $2.25B | Mid cap | +135.11% |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +4.47% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.20B | Mid cap | +36.58% |
| 008930.KS | Hanmi Science Co., Ltd. | $2.20B | Mid cap | +9.26% |
| 9987.T | Suzuken Co., Ltd. | $2.19B | Mid cap | −9.81% |
| GN.CO | GN Store Nord A/S | $2.19B | Mid cap | −16.23% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% |
| 302440.KS | SK bioscience Co.,Ltd. | $2.18B | Mid cap | −17.57% |
| XRAY | DENTSPLY SIRONA Inc. | $2.18B | Mid cap | −21.61% |
| EXE.TO | Extendicare Inc. | $2.18B | Mid cap | +146.56% |
| VCEL | Vericel Corporation | $2.17B | Mid cap | +18.25% |
| EKTA-B.ST | Elekta AB (publ) | $2.16B | Mid cap | +22.79% |
| ADMA | ADMA Biologics, Inc. | $2.16B | Mid cap | −44.17% |
| HCM.L | HUTCHMED (China) Limited | $2.16B | Mid cap | −17.57% |
| ZBIO | Zenas BioPharma, Inc. | $2.15B | Mid cap | +97.73% |
| ALIF-B.ST | AddLife AB (publ) | $2.15B | Mid cap | −4.16% |
| ESTA | Establishment Labs Holdings Inc. | $2.15B | Mid cap | +70.71% |
| CLOV34.SA | Clover Health Investments, Corp. | $2.15B | Mid cap | +45.23% |
| HCM | HUTCHMED (China) Limited | $2.15B | Mid cap | −17.45% |
| STOK | Stoke Therapeutics, Inc. | $2.14B | Mid cap | +71.45% |
| GNS.L | Genus plc | $2.12B | Mid cap | −10.24% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
| NVCR | NovoCure Limited | $2.08B | Mid cap | +50.21% |
| GENB | Generate Biomedicines, Inc. | $2.07B | Mid cap | +27.59% |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +28.14% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $2.03B | Mid cap | −13.45% |
| CMPS | COMPASS Pathways plc | $2.02B | Mid cap | +209.53% |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.01B | Mid cap | +80.63% |
| GHRS | GH Research PLC | $1.99B | Small cap | +112.84% |
| PIII | P3 Health Partners Inc. | $1.98B | Small cap | +26.37% |
| PGNY | Progyny, Inc. | $1.98B | Small cap | +14.55% |
| S1RP34.SA | Sarepta Therapeutics, Inc. | $1.98B | Small cap | −12.20% |
| FLRY3.SA | Fleury S.A. | $1.97B | Small cap | +37.82% |
| TSHA | Taysha Gene Therapies, Inc. | $1.96B | Small cap | +102.69% |
| VIMIAN.ST | Vimian Group AB (publ) | $1.96B | Small cap | +14.54% |
| EMBLA.CO | Embla Medical hf. | $1.96B | Small cap | −5.97% |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +13.69% |
| GXE.DE | Lakefront Biotherapeutics NV | $1.92B | Small cap | −43.15% |
| ASTH | Astrana Health, Inc. | $1.92B | Small cap | +23.71% |
| LKFT | Lakefront Biotherapeutics NV | $1.91B | Small cap | −11.39% |
| SNDA | Sonida Senior Living, Inc. | $1.91B | Small cap | +51.53% |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +15.50% |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +804.46% |
| SEPN | Septerna, Inc. | $1.88B | Small cap | +218.81% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.87B | Small cap | −28.63% |
| NEU.AX | Neuren Pharmaceuticals Limited | $1.87B | Small cap | +7.57% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | $1.86B | Small cap | +59.38% |
| SGRY | Surgery Partners, Inc. | $1.84B | Small cap | −38.48% |
| PSNL | Personalis, Inc. | $1.82B | Small cap | +257.32% |
| LMAT | LeMaitre Vascular, Inc. | $1.81B | Small cap | −16.20% |
| INSP | Inspire Medical Systems, Inc. | $1.79B | Small cap | −33.04% |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.96% |
| 4540.T | Tsumura & Co. | $1.77B | Small cap | +11.13% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +23.55% |
| ALVO-SDB.ST | Alvotech | $1.76B | Small cap | −39.34% |
| FTRE | Fortrea Holdings Inc. | $1.76B | Small cap | +105.20% |
| ALVO | Alvotech | $1.75B | Small cap | −38.85% |
| ANAB | AnaptysBio, Inc. | $1.73B | Small cap | +326.47% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.71B | Small cap | −18.85% |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +113.27% |
| SIA.TO | Sienna Senior Living Inc. | $1.65B | Small cap | +25.96% |
| 7716.T | Nakanishi Inc. | $1.65B | Small cap | +51.84% |
| AVLN | Avalyn Pharma Inc. | $1.64B | Small cap | +25.60% |
| BCAX | Bicara Therapeutics Inc. | $1.64B | Small cap | +105.74% |
| AGL | agilon health, inc. | $1.61B | Small cap | +194.58% |
| 8129.T | Toho Holdings Co., Ltd. | $1.60B | Small cap | −24.88% |
| RDC.DE | Redcare Pharmacy NV | $1.60B | Small cap | −16.64% |
| PYC.AX | PYC Therapeutics Limited | $1.59B | Small cap | +75.78% |
| CLARI.PA | Clariane SE | $1.59B | Small cap | −11.31% |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.59B | Small cap | −25.84% |
| ARDT | Ardent Health, Inc. | $1.58B | Small cap | −11.64% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.58B | Small cap | +8.64% |
| ABSI | Absci Corporation | $1.58B | Small cap | +261.57% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.58B | Small cap | +132.58% |
| AAPG | Ascentage Pharma Group Internat | $1.58B | Small cap | −59.18% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | $1.58B | Small cap | +298.89% |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% |
| 4DX.AX | 4DMedical Limited | $1.57B | Small cap | +538.60% |
| 8086.T | Nipro Corporation | $1.56B | Small cap | +3.46% |
| TYRA | Tyra Biosciences, Inc. | $1.56B | Small cap | +103.57% |
| KMTS | Kestra Medical Technologies, Ltd. | $1.56B | Small cap | +47.61% |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% |
| AVBP | ArriVent BioPharma, Inc. | $1.54B | Small cap | +62.10% |
| CNMD | CONMED Corporation | $1.53B | Small cap | −6.91% |
| DIA.WA | Diagnostyka S.A. | $1.53B | Small cap | −16.84% |
| INVA | Innoviva, Inc. | $1.53B | Small cap | +7.06% |
| OMCL | Omnicell, Inc. | $1.53B | Small cap | +0.66% |
| NVAX | Novavax, Inc. | $1.52B | Small cap | +21.50% |
| 4516.T | Nippon Shinyaku Co., Ltd. | $1.52B | Small cap | +18.39% |
| NOLA-B.ST | Nolato AB (publ) | $1.51B | Small cap | −4.79% |
| 6849.T | Nihon Kohden Corporation | $1.50B | Small cap | −6.90% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| SPTX | Seaport Therapeutics, Inc. | $1.49B | Small cap | +40.32% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $1.49B | Small cap | +74.45% |
| INNV | InnovAge Holding Corp. | $1.48B | Small cap | +178.79% |
| AKTS | Aktis Oncology, Inc. | $1.47B | Small cap | +18.35% |
| AZTA | Azenta, Inc. | $1.47B | Small cap | +11.16% |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +2.74% |
| PAHC | Phibro Animal Health Corporation | $1.46B | Small cap | +13.01% |
| SDGR | Schrödinger, Inc. | $1.46B | Small cap | −1.62% |
| ENOV | Enovis Corporation | $1.46B | Small cap | −18.60% |
| ATEC | Alphatec Holdings, Inc. | $1.45B | Small cap | −41.78% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.44B | Small cap | +35.58% |
| 4483.T | JMDC Inc. | $1.44B | Small cap | −15.45% |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% |
| GDS.PA | Ramsay Générale de Santé SA | $1.41B | Small cap | +10.00% |
| IMTX | Immatics N.V. | $1.41B | Small cap | +74.63% |
| F9L.F | Joincare Pharmaceutical Group Industry Co.,Ltd. | $1.40B | Small cap | −48.02% |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +168.30% |
| VITR.ST | Vitrolife AB (publ) | $1.39B | Small cap | −28.19% |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% |
| 3148.T | Create SD Holdings Co., Ltd. | $1.38B | Small cap | +1.90% |
| 9627.T | Ain Holdings Inc. | $1.37B | Small cap | +3.62% |
| 3360.T | Ship Healthcare Holdings, Inc. | $1.35B | Small cap | +8.75% |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% |
| PNTG | The Pennant Group, Inc. | $1.34B | Small cap | +56.31% |
| UPR.L | Uniphar plc | $1.33B | Small cap | +4.55% |
| AORT | Artivion, Inc. | $1.33B | Small cap | −37.81% |
| AMN | AMN Healthcare Services, Inc. | $1.33B | Small cap | +70.26% |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% |
| REG.AX | Regis Healthcare Limited | $1.32B | Small cap | −20.56% |
| MNKD | MannKind Corporation | $1.32B | Small cap | −9.51% |
| CRON.TO | Cronos Group Inc. | $1.31B | Small cap | +39.83% |
| CRON | Cronos Group Inc. | $1.31B | Small cap | +38.67% |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +13.52% |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% |
| RYM.AX | RYM FPO NZX [RYM] | $1.29B | Small cap | −27.80% |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +9.22% |
| 2175.T | SMS Co., Ltd. | $1.27B | Small cap | +58.30% |
| 4544.T | H.U. Group Holdings, Inc. | $1.25B | Small cap | +3.16% |
| SANA | Sana Biotechnology, Inc. | $1.25B | Small cap | +23.44% |
| GDRX | GoodRx Holdings, Inc. | $1.25B | Small cap | −18.89% |
| CERT | Certara, Inc. | $1.24B | Small cap | −25.07% |
| SNZ.AX | Summerset Group Holdings Limited | $1.24B | Small cap | −27.67% |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +14.57% |
| ODTX | Odyssey Therapeutics, Inc. | $1.23B | Small cap | +56.03% |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.23B | Small cap | +207.92% |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.82% |
| 4553.T | Towa Pharmaceutical Co., Ltd. | $1.21B | Small cap | +38.84% |
| PRCT | PROCEPT BioRobotics Corporation | $1.21B | Small cap | −48.36% |
| 2160.T | GNI Group Ltd. | $1.20B | Small cap | +8.51% |
| CVSG.L | CVS Group plc | $1.19B | Small cap | +5.94% |
| IVA.PA | Inventiva S.A. | $1.17B | Small cap | −13.48% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +110.53% |
| USPH | U.S. Physical Therapy, Inc. | $1.17B | Small cap | −5.67% |
| 4887.T | Sawai Group Holdings Co., Ltd. | $1.17B | Small cap | −11.69% |
| KURA | Kura Oncology, Inc. | $1.16B | Small cap | +66.16% |
| SPH.WA | Sopharma AD | $1.15B | Small cap | −37.61% |
| TDOC | Teladoc Health, Inc. | $1.15B | Small cap | −18.22% |
| SVRA | Savara Inc. | $1.15B | Small cap | +70.52% |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.15B | Small cap | −35.42% |
| STAA | STAAR Surgical Company | $1.15B | Small cap | −16.90% |
| TTALO.HE | Terveystalo Oyj | $1.14B | Small cap | −22.07% |
| IVA | Inventiva S.A. | $1.14B | Small cap | −7.84% |
| T2DH34.SA | Teladoc Health, Inc. | $1.13B | Small cap | −24.67% |
| 7476.T | AS ONE Corporation | $1.12B | Small cap | +2.25% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | $1.12B | Small cap | +24.68% |
| IRMD | IRADIMED CORPORATION | $1.12B | Small cap | +19.80% |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +6.34% |
| AVTX | Avalo Therapeutics, Inc. | $1.10B | Small cap | +112.95% |
| PHIL.MI | Philogen S.p.A. | $1.09B | Small cap | +2.99% |
| 006280.KS | GC Biopharma Corp. | $1.09B | Small cap | +1.63% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | $1.08B | Small cap | +35.66% |
| 069620.KS | Daewoong Pharmaceutical Co., Ltd | $1.08B | Small cap | −4.97% |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | $1.07B | Small cap | −1.73% |
| GXI.DE | Gerresheimer AG | $1.05B | Small cap | −41.09% |
| SLDB | Solid Biosciences Inc. | $1.04B | Small cap | +72.95% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $1.04B | Small cap | +104.42% |
| CSTL | Castle Biosciences, Inc. | $1.04B | Small cap | +52.96% |
| MEDCL.PA | MedinCell S.A. | $1.03B | Small cap | +43.09% |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −48.12% |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% |
| GUBRA.CO | Gubra A/S | $1.03B | Small cap | +6.82% |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% |
| PCRX | Pacira BioSciences, Inc. | $1.02B | Small cap | −0.88% |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% |
| GERN | Geron Corporation | $995.83M | Small cap | +8.51% |
| 7730.T | Mani, Inc. | $994.58M | Small cap | +31.25% |
| DSGN | Design Therapeutics, Inc. | $975.65M | Small cap | +194.71% |
| NEU.WA | NEUCA S.A. | $971.18M | Small cap | +22.80% |
| EUZ.DE | Eckert & Ziegler SE | $965.07M | Small cap | −22.81% |
| VETO.PA | Vetoquinol SA | $961.38M | Small cap | −6.46% |
| BVS | Bioventus Inc. | $954.22M | Small cap | +86.52% |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | $947.00M | Small cap | +9.96% |
| ANNX | Annexon, Inc. | $946.00M | Small cap | +136.49% |
| DBVT | DBV Technologies S.A. | $940.80M | Small cap | +53.00% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $936.96M | Small cap | +68.75% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $934.98M | Small cap | −27.78% |
| DBV.PA | DBV Technologies S.A. | $923.84M | Small cap | +56.64% |
| CLYM | Climb Bio Inc | $923.57M | Small cap | +603.72% |
| PHN.MI | Pharmanutra S.p.A. | $913.46M | Small cap | +70.81% |
| 3046.T | JINS HOLDINGS Inc. | $911.23M | Small cap | −23.78% |
| ACRS | Aclaris Therapeutics, Inc. | $911.16M | Small cap | +240.11% |
| B2RK34.SA | Bruker Corporation | $906.52M | Small cap | +63.27% |
| CBLL | CeriBell, Inc. | $899.97M | Small cap | +102.16% |
| 4587.T | PeptiDream Inc. | $898.07M | Small cap | −25.72% |
| SGP | SpyGlass Pharma, Inc. | $891.05M | Small cap | +0.91% |
| ANL | Adlai Nortye Ltd. | $884.83M | Small cap | +791.12% |
| TBPH | Theravance Biopharma, Inc. | $884.18M | Small cap | +23.41% |
| MCAP.ST | MedCap AB (publ) | $879.89M | Small cap | −9.69% |
| 7780.T | Menicon Co., Ltd. | $873.71M | Small cap | +58.71% |
| GNFT.PA | Genfit S.A. | $870.63M | Small cap | +327.25% |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +93.73% |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +1.95% |
| AVR.AX | Anteris Technologies Global Corp. | $866.22M | Small cap | +120.54% |
| AVR | Anteris Technologies Global Corp. | $865.37M | Small cap | +144.54% |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +16.99% |
| INMD | InMode Ltd. | $864.89M | Small cap | −1.71% |
| SYNSAM.ST | Synsam AB (publ) | $864.35M | Small cap | +1.95% |
| SIBN | SI-BONE, Inc. | $861.71M | Small cap | +17.12% |
| OXB.L | Oxford Biomedica plc | $860.16M | Small cap | −6.01% |
| FDMT | 4D Molecular Therapeutics, Inc. | $859.60M | Small cap | +140.87% |
| 4694.T | BML, Inc. | $858.68M | Small cap | +6.14% |
| DYVOX.ST | Dynavox Group AB (publ) | $855.06M | Small cap | −38.08% |
| COLL | Collegium Pharmaceutical, Inc. | $852.79M | Small cap | −29.08% |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% |
| AHG | Akso Health Group | $848.14M | Small cap | −43.10% |
| PHAR | Pharming Group N.V. | $845.80M | Small cap | −14.47% |
| APOTEA.ST | Apotea AB (publ) | $845.55M | Small cap | −24.60% |
| SLN | Silence Therapeutics plc | $840.94M | Small cap | +160.19% |
| HSTM | HealthStream, Inc. | $840.94M | Small cap | +1.86% |
| SFL.MI | Safilo Group S.p.A. | $839.99M | Small cap | +21.52% |
| AMS.L | Advanced Medical Solutions Group plc | $831.56M | Small cap | +39.03% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $819.46M | Small cap | +45.87% |
| NVCT | Nuvectis Pharma, Inc. | $816.10M | Small cap | +275.94% |
| WELL.TO | WELL Health Technologies Corp. | $807.72M | Small cap | −8.18% |
| 001067.KS | JW Pharmaceutical Corporation | $806.37M | Small cap | −23.44% |
| ARJO-B.ST | Arjo AB (publ) | $805.01M | Small cap | −15.46% |
| AURA | Aura Biosciences, Inc. | $801.64M | Small cap | +20.03% |
| STTK | Shattuck Labs, Inc. | $792.87M | Small cap | +690.00% |
| SNT.WA | Synektik Spólka Akcyjna | $772.46M | Small cap | +56.15% |
| AHCO | AdaptHealth Corp. | $771.43M | Small cap | −38.44% |
| NGNE | Neurogene Inc. | $768.64M | Small cap | +95.02% |
| MNPR | Monopar Therapeutics Inc. | $763.31M | Small cap | +226.69% |
| DRUG | Bright Minds Biosciences Inc. | $751.90M | Small cap | +76.73% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $751.23M | Small cap | −0.43% |
| UU8.F | Neurogene Inc. | $748.28M | Small cap | +157.60% |
| EIQ.AX | Echo IQ Limited | $743.66M | Small cap | +564.29% |
| D2OC34.SA | Doximity, Inc. | $733.94M | Small cap | −65.76% |
| 4534.T | Mochida Pharmaceutical Co., Ltd. | $730.42M | Small cap | +8.26% |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% |
| ASMB | Assembly Biosciences, Inc. | $721.17M | Small cap | +36.81% |
| OCS | Oculis Holding AG | $720.20M | Small cap | −25.14% |
| PHR | Phreesia, Inc. | $716.58M | Small cap | −63.74% |
| SSII | SS Innovations International, Inc. | $715.38M | Small cap | −50.55% |
| DHT-UN.TO | DRI Healthcare Trust | $714.70M | Small cap | +27.29% |
| XOMA | XOMA Royalty Corp | $710.16M | Small cap | +19.27% |
| PHAT | Phathom Pharmaceuticals, Inc. | $709.50M | Small cap | −29.50% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $708.88M | Small cap | +240.48% |
| 9267.T | Genky DrugStores Co., Ltd. | $707.77M | Small cap | −18.11% |
| GYRE | Gyre Therapeutics, Inc. | $705.12M | Small cap | −18.00% |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% |
| C2RS34.SA | CRISPR Therapeutics AG | $704.10M | Small cap | +0.85% |
| EVT.DE | Evotec SE | $703.33M | Small cap | −43.20% |
| AGMB | AgomAb Therapeutics NV | $703.26M | Small cap | −2.53% |
| TECX | Tectonic Therapeutic, Inc. | $703.19M | Small cap | +35.43% |
| ZVRA | Zevra Therapeutics, Inc. | $697.17M | Small cap | +25.43% |
| 7575.T | Japan Lifeline Co., Ltd. | $696.48M | Small cap | +13.61% |
| PROK | ProKidney Corp. | $694.58M | Small cap | −30.12% |
| EVO | Evotec SE | $693.01M | Small cap | −44.13% |
| GMRS | GMR Solutions Inc. | $692.56M | Small cap | −8.30% |
| GUD.TO | Knight Therapeutics Inc. | $690.78M | Small cap | +50.39% |
| DHT-U.TO | DRI Healthcare Trust | $690.34M | Small cap | +27.68% |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −20.13% |
| CU6.AX | Clarity Pharmaceuticals Ltd | $673.94M | Small cap | −15.77% |
| CBIO | Crescent Biopharma, Inc. | $669.39M | Small cap | +26.46% |
| 185750.KS | Chong Kun Dang Pharmaceutical Corp. | $657.93M | Small cap | −13.76% |
| CRMD | CorMedix Inc. | $653.95M | Small cap | −40.66% |
| LBIRD.PA | Lumibird SA | $650.27M | Small cap | +59.66% |
| PRME | Prime Medicine, Inc. | $649.33M | Small cap | +4.37% |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% |
| MDXG | MiMedx Group, Inc. | $644.26M | Small cap | −38.35% |
| 2HQ0.DE | Tilray Brands, Inc. | $643.43M | Small cap | −67.32% |
| 4565.T | Nxera Pharma Co., Ltd. | $642.58M | Small cap | +21.30% |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −20.45% |
| TLRY.TO | Tilray Brands, Inc. | $640.36M | Small cap | +240.00% |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% |
| KIDS | OrthoPediatrics Corp. | $639.69M | Small cap | +11.10% |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% |
| CTEV | Claritev Corporation | $636.72M | Small cap | −47.71% |
| VALN | Valneva SE | $634.84M | Small cap | −23.49% |
| 6197.T | Solasto Corporation | $634.50M | Small cap | +138.65% |
| CRW.L | Craneware plc | $633.59M | Small cap | −37.84% |
| DASA3.SA | Diagnósticos da América S.A. | $633.57M | Small cap | +93.33% |
| AYJ.DE | Valneva SE | $629.58M | Small cap | −26.20% |
| VLA.PA | Valneva SE | $629.58M | Small cap | −25.39% |
| AUTL | Autolus Therapeutics plc | $620.16M | Small cap | +48.41% |
| ARVN | Arvinas, Inc. | $609.40M | Small cap | +15.35% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.